Related Experiment Videos

Management of acute coronary syndrome in a case of Behçet's disease

Mehmet Ergelen1, Ozer Soylu, Huseyin Uyarel

  • 1Department of Cardiology, Siyami Ersek Cardiovascular and Thoracic Surgery Center, Istanbul, Turkey. drmerg@hotmail.com

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|September 30, 2009
PubMed

Insights

This study reports the first case of left main coronary artery thrombosis in Behcet's disease, a rare cardiac manifestation. The patient successfully recovered with thrombolytic therapy and glycoprotein IIb/IIIa inhibitors.

Area of Science:

  • Rheumatology
  • Cardiology
  • Vascular Inflammation

Background:

  • Behcet's disease is a multisystemic inflammatory condition.
  • Cardiac involvement, including coronary arteritis, is a known but infrequent complication.
  • Left main coronary artery thrombosis is an exceptionally rare presentation.

Observation:

  • A patient with Behcet's disease presented with symptoms indicative of acute myocardial infarction.
  • Diagnostic imaging revealed thrombosis in the left main coronary artery.

Findings:

  • This case represents the first documented instance of left main coronary artery thrombosis in the context of Behcet's disease.
  • The patient received successful treatment utilizing thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibitors.

Implications:

  • Highlights the potential for severe coronary artery complications in Behcet's disease.
  • Demonstrates the efficacy of specific pharmacotherapies in managing this rare cardiovascular manifestation.
  • Suggests the importance of considering coronary angiography in Behcet's patients with cardiac symptoms.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...